Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
 4件: BRAF, FLT3, KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
2 Acute myeloid leukemia 💬
 4件: BRAF, FLT3, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
3 Acute myeloid leukemia 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
4 Acute myeloid leukemia 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
5 Acute myeloid leukemia 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
6 Acute myeloid leukemia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
7 Adherens junction 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
8 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
9 Adipocytokine signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
10 Adipocytokine signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
11 Adrenergic signaling in cardiomyocytes 💬
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
12 Adrenergic signaling in cardiomyocytes 💬
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
13 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
14 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
15 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB2 💬 D02147 💬 Salbutamol 14件:  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
16 Adrenergic signaling in cardiomyocytes 💬
 2件: AGTR1, AGTR2 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
17 Adrenergic signaling in cardiomyocytes 💬
 2件: AGTR1, AGTR2 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
18 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
19 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
20 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
21 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
22 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
23 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
24 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D02086 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
25 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
26 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
27 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
28 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
29 Alcoholic liver disease 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
30 Alcoholic liver disease 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
31 Alcoholic liver disease 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
32 Alcoholism 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
33 Alcoholism 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
34 Alcoholism 💬
 1件: DRD2 💬 D01462 💬 Lisuride 2件:  6 , 86 💬
35 Alcoholism 💬
 1件: DRD2 💬 D08132 💬 Lisuride 2件:  6 , 86 💬
36 Alcoholism 💬
 1件: DRD2 💬 D01348 💬 Terguride 2件: 51, 86 💬
37 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
38 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
39 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
40 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
41 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
42 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
43 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
44 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
45 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
46 Aldosterone-regulated sodium reabsorption 💬
 1件: NR3C2 💬 D00443 💬 Spironolactone 7件: 58, 67, 86, 113, 210, 218, 225 💬
47 Alzheimer disease 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
48 Alzheimer disease 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
49 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
50 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
51 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
52 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
53 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
54 Alzheimer disease 💬
 3件: CHRM1, CHRM3, CHRM5 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
55 Alzheimer disease 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
56 Alzheimer disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
57 Alzheimer disease 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
58 Alzheimer disease 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
59 Amoebiasis 💬
 2件: IL1R1, IL1R2 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
60 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
61 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
62 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
63 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
64 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
65 AMPK signaling pathway 💬
 1件: ADRA1A 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
66 AMPK signaling pathway 💬
 1件: ADRA1A 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
67 AMPK signaling pathway 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
68 AMPK signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
69 AMPK signaling pathway 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
70 AMPK signaling pathway 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
71 AMPK signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
72 AMPK signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
73 Amyotrophic lateral sclerosis 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
74 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
75 Apelin signaling pathway 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
76 Apelin signaling pathway 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
77 Apelin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
78 Apelin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
79 Apelin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
80 Apelin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
81 Apelin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
82 Apoptosis 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
83 Apoptosis 💬
 2件: PARP1, PARP2 💬 D09730 💬 Olaparib 2件: 86, 285 💬
84 Apoptosis 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
85 Apoptosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
86 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
87 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
88 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
89 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
90 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
91 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
92 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
93 Autophagy - animal 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
94 Autophagy - animal 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
95 Autophagy - animal 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
96 Autophagy - animal 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
97 Autophagy - animal 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
98 Autophagy - other 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
99 Axon guidance 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
100 Axon guidance 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
101 Axon guidance 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
102 Axon guidance 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
103 Axon guidance 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
104 B cell receptor signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
105 B cell receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
106 Base excision repair 💬
 2件: PARP1, PARP2 💬 D09730 💬 Olaparib 2件: 86, 285 💬
107 Bile secretion 💬
 1件: CA2 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
108 Bile secretion 💬
 1件: CA2 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
109 Bile secretion 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
110 Biosynthesis of cofactors 💬
 2件: NQO1, VKORC1 💬 D00564 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
111 Biosynthesis of cofactors 💬
 2件: NQO1, VKORC1 💬 D01280 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
112 Biosynthesis of cofactors 💬
 2件: NQO1, VKORC1 💬 D08682 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
113 Bladder cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
114 Bladder cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
115 Bladder cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
116 Bladder cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
117 Breast cancer 💬
 4件: BRAF, FLT4, KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
118 Breast cancer 💬
 4件: BRAF, FLT4, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
119 Breast cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
120 Breast cancer 💬
 2件: ESR1, ESR2 💬 D01161 💬 Fulvestrant 2件: 49, 86 💬
121 Breast cancer 💬
 2件: ESR1, ESR2 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
122 Breast cancer 💬
 2件: ESR1, ESR2 💬 D00966 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
123 Breast cancer 💬
 2件: ESR1, ESR2 💬 D08559 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
124 Breast cancer 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
125 Breast cancer 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
126 Breast cancer 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
127 Breast cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
128 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
129 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
130 C-type lectin receptor signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
131 C-type lectin receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
132 Calcium signaling pathway 💬
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
133 Calcium signaling pathway 💬
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
134 Calcium signaling pathway 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
135 Calcium signaling pathway 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
136 Calcium signaling pathway 💬
 1件: ADRB2 💬 D02147 💬 Salbutamol 14件:  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
137 Calcium signaling pathway 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
138 Calcium signaling pathway 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
139 Calcium signaling pathway 💬
 1件: AVPR1A 💬 D01236 💬 Conivaptan 1件: 86 💬
140 Calcium signaling pathway 💬
 1件: AVPR1A 💬 D07748 💬 Conivaptan 1件: 86 💬
141 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
142 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
143 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
144 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
145 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
146 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
147 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
148 Calcium signaling pathway 💬
 4件: CHRM1, CHRM2, CHRM3, CHRM5 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
149 Calcium signaling pathway 💬
 1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
150 Calcium signaling pathway 💬
 1件: EDNRA 💬 D07171 💬 Sitaxentan 1件: 86 💬
151 Calcium signaling pathway 💬
 2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
152 Calcium signaling pathway 💬
 2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
153 Calcium signaling pathway 💬
 2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
154 Calcium signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
155 Calcium signaling pathway 💬
 4件: FLT4, KDR, PDGFRB, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
156 Calcium signaling pathway 💬
 4件: FLT4, KDR, PDGFRB, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
157 Calcium signaling pathway 💬
 1件: HRH1 💬 D00300 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
158 Calcium signaling pathway 💬
 1件: HRH1 💬 D00669 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
159 Calcium signaling pathway 💬
 1件: HRH1 💬 D02419 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
160 Calcium signaling pathway 💬
 1件: HRH1 💬 D03285 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
161 Calcium signaling pathway 💬
 1件: HRH1 💬 D03360 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
162 Calcium signaling pathway 💬
 1件: HRH1 💬 D03854 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
163 Calcium signaling pathway 💬
 1件: HRH2 💬 D00318 💬 Famotidine 7件:  6 , 46, 61, 86, 98, 107, 300 💬
164 Calcium signaling pathway 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
165 Calcium signaling pathway 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
166 Calcium signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
167 Calcium signaling pathway 💬
 1件: TBXA2R 💬 D04500 💬 Ifetroban 3件: 51, 86, 113 💬
168 Calcium signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
169 cAMP signaling pathway 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
170 cAMP signaling pathway 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
171 cAMP signaling pathway 💬
 2件: ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
172 cAMP signaling pathway 💬
 2件: ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
173 cAMP signaling pathway 💬
 1件: ADRB2 💬 D02147 💬 Salbutamol 14件:  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
174 cAMP signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
175 cAMP signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
176 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
177 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
178 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
179 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
180 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
181 cAMP signaling pathway 💬
 2件: CHRM1, CHRM2 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
182 cAMP signaling pathway 💬
 1件: DRD2 💬 D01462 💬 Lisuride 2件:  6 , 86 💬
183 cAMP signaling pathway 💬
 1件: DRD2 💬 D08132 💬 Lisuride 2件:  6 , 86 💬
184 cAMP signaling pathway 💬
 1件: DRD2 💬 D01348 💬 Terguride 2件: 51, 86 💬
185 cAMP signaling pathway 💬
 1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
186 cAMP signaling pathway 💬
 1件: EDNRA 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
187 cAMP signaling pathway 💬
 1件: EDNRA 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
188 cAMP signaling pathway 💬
 1件: EDNRA 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
189 cAMP signaling pathway 💬
 1件: EDNRA 💬 D07171 💬 Sitaxentan 1件: 86 💬
190 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
191 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
192 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
193 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
194 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
195 Carbohydrate digestion and absorption 💬
 2件: TAS1R2, TAS1R3 💬 D02381 💬 Aspartame 5件:  6 , 13, 67, 86, 230 💬
196 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
197 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
198 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
199 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
200 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
201 Cell cycle 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
202 Cell cycle 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
203 Cell cycle 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
204 Cellular senescence 💬
 1件: CACNA1D 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
205 Cellular senescence 💬
 1件: CACNA1D 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
206 Cellular senescence 💬
 1件: CACNA1D 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
207 Cellular senescence 💬
 1件: CACNA1D 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
208 Cellular senescence 💬
 1件: CACNA1D 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
209 Cellular senescence 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
210 Cellular senescence 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
211 Cellular senescence 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
212 Central carbon metabolism in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
213 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
214 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
215 Central carbon metabolism in cancer 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
216 Central carbon metabolism in cancer 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
217 Central carbon metabolism in cancer 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
218 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
219 cGMP-PKG signaling pathway 💬
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
220 cGMP-PKG signaling pathway 💬
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
221 cGMP-PKG signaling pathway 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
222 cGMP-PKG signaling pathway 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
223 cGMP-PKG signaling pathway 💬
 1件: ADRB2 💬 D02147 💬 Salbutamol 14件:  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
224 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
225 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
226 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
227 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
228 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
229 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
230 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
231 cGMP-PKG signaling pathway 💬
 1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
232 cGMP-PKG signaling pathway 💬
 1件: EDNRA 💬 D07171 💬 Sitaxentan 1件: 86 💬
233 cGMP-PKG signaling pathway 💬
 2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
234 cGMP-PKG signaling pathway 💬
 2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
235 cGMP-PKG signaling pathway 💬
 2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
236 cGMP-PKG signaling pathway 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
237 cGMP-PKG signaling pathway 💬
 1件: PDE5A 💬 D02229 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
238 cGMP-PKG signaling pathway 💬
 1件: PDE5A 💬 D08514 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
239 cGMP-PKG signaling pathway 💬
 1件: PDE5A 💬 D02008 💬 Tadalafil 7件:  6 , 51, 75, 84, 86, 113, 210 💬
240 cGMP-PKG signaling pathway 💬
 1件: PDE5A 💬 D10027 💬 Udenafil 2件: 86, 210 💬
241 cGMP-PKG signaling pathway 💬
 1件: PDE5A 💬 D02731 💬 Vardenafil 3件: 13, 86, 299 💬
242 cGMP-PKG signaling pathway 💬
 1件: PDE5A 💬 D03260 💬 Vardenafil 3件: 13, 86, 299 💬
243 cGMP-PKG signaling pathway 💬
 1件: PDE5A 💬 D08668 💬 Vardenafil 3件: 13, 86, 299 💬
244 cGMP-PKG signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
245 cGMP-PKG signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
246 Chagas disease 💬
 1件: ACE 💬 D00251 💬 Captopril 8件:  6 , 17, 46, 86, 96, 97, 107, 271 💬
247 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
248 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
249 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
250 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
251 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
252 Chemical carcinogenesis - reactive oxygen species 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
253 Chemical carcinogenesis - reactive oxygen species 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
254 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
255 Chemical carcinogenesis - reactive oxygen species 💬
 1件: KEAP1 💬 D03846 💬 Dimethyl fumarate 5件: 13, 49, 51, 86, 296 💬
256 Chemical carcinogenesis - reactive oxygen species 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
257 Chemical carcinogenesis - reactive oxygen species 💬
 1件: NQO1 💬 D00564 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
258 Chemical carcinogenesis - reactive oxygen species 💬
 1件: NQO1 💬 D01280 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
259 Chemical carcinogenesis - reactive oxygen species 💬
 1件: NQO1 💬 D08682 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
260 Chemical carcinogenesis - reactive oxygen species 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
261 Chemical carcinogenesis - receptor activation 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
262 Chemical carcinogenesis - receptor activation 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
263 Chemical carcinogenesis - receptor activation 💬
 2件: ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
264 Chemical carcinogenesis - receptor activation 💬
 2件: ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
265 Chemical carcinogenesis - receptor activation 💬
 1件: ADRB2 💬 D02147 💬 Salbutamol 14件:  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
266 Chemical carcinogenesis - receptor activation 💬
 3件: AR, ESR1, ESR2 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
267 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
268 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
269 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
270 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
271 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
272 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
273 Chemical carcinogenesis - receptor activation 💬
 2件: ESR1, ESR2 💬 D01161 💬 Fulvestrant 2件: 49, 86 💬
274 Chemical carcinogenesis - receptor activation 💬
 2件: ESR1, ESR2 💬 D00966 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
275 Chemical carcinogenesis - receptor activation 💬
 2件: ESR1, ESR2 💬 D08559 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
276 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
277 Chemical carcinogenesis - receptor activation 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
278 Chemical carcinogenesis - receptor activation 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
279 Chemical carcinogenesis - receptor activation 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
280 Chemokine signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
281 Chemokine signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
282 Choline metabolism in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
283 Choline metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
284 Choline metabolism in cancer 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
285 Choline metabolism in cancer 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
286 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
287 Choline metabolism in cancer 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
288 Choline metabolism in cancer 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
289 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
290 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
291 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
292 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
293 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
294 Cholinergic synapse 💬
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
295 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
296 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
297 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
298 Chronic myeloid leukemia 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
299 Chronic myeloid leukemia 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
300 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
301 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
302 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
303 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
304 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
305 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
306 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
307 Circadian entrainment 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
308 Circadian rhythm 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
309 Circadian rhythm 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
310 Cocaine addiction 💬
 1件: DRD2 💬 D01462 💬 Lisuride 2件:  6 , 86 💬
311 Cocaine addiction 💬
 1件: DRD2 💬 D08132 💬 Lisuride 2件:  6 , 86 💬
312 Cocaine addiction 💬
 1件: DRD2 💬 D01348 💬 Terguride 2件: 51, 86 💬
313 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 D01984 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
314 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 D04056 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
315 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 D07917 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
316 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 D09339 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
317 Collecting duct acid secretion 💬
 1件: CA2 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
318 Collecting duct acid secretion 💬
 1件: CA2 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
319 Colorectal cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
320 Colorectal cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
321 Colorectal cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
322 Colorectal cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
323 Coronavirus disease - COVID-19 💬
 1件: ACE 💬 D00251 💬 Captopril 8件:  6 , 17, 46, 86, 96, 97, 107, 271 💬
324 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
325 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
326 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
327 Coronavirus disease - COVID-19 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
328 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
329 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
330 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
331 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
332 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
333 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
334 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
335 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
336 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
337 Cushing syndrome 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
338 Cushing syndrome 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
339 Cushing syndrome 💬
 1件: BRAF 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
340 Cushing syndrome 💬
 1件: BRAF 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
341 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
342 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
343 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
344 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
345 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
346 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
347 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
348 Cushing syndrome 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
349 Cytokine-cytokine receptor interaction 💬
 1件: ACVR2A 💬 D09670 💬 Sotatercept 2件: 86, 284 💬
350 Cytokine-cytokine receptor interaction 💬
 2件: IL1R1, IL1R2 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
351 Cytokine-cytokine receptor interaction 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
352 Cytokine-cytokine receptor interaction 💬
 1件: PRL 💬 D01348 💬 Terguride 2件: 51, 86 💬
353 Diabetic cardiomyopathy 💬
 1件: ACE 💬 D00251 💬 Captopril 8件:  6 , 17, 46, 86, 96, 97, 107, 271 💬
354 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
355 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
356 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
357 Diabetic cardiomyopathy 💬
 1件: PARP1 💬 D09730 💬 Olaparib 2件: 86, 285 💬
358 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
359 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
360 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
361 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
362 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
363 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
364 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
365 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
366 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
367 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
368 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
369 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
370 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
371 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
372 Dopaminergic synapse 💬
 1件: DRD2 💬 D01348 💬 Terguride 2件: 51, 86 💬
373 Dopaminergic synapse 💬
 3件: DRD2, DRD3, DRD4 💬 D01462 💬 Lisuride 2件:  6 , 86 💬
374 Dopaminergic synapse 💬
 3件: DRD2, DRD3, DRD4 💬 D08132 💬 Lisuride 2件:  6 , 86 💬
375 Dopaminergic synapse 💬
 1件: SCN1A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
376 Dopaminergic synapse 💬
 1件: SCN1A 💬 D02086 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
377 Dopaminergic synapse 💬
 1件: SCN1A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
378 Drug metabolism - other enzymes 💬
 1件: RRM2 💬 D00341 💬 Hydroxyurea 8件:  3 , 13, 19, 20, 65, 85, 86, 284 💬
379 EGFR tyrosine kinase inhibitor resistance 💬
 4件: BRAF, KDR, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
380 EGFR tyrosine kinase inhibitor resistance 💬
 4件: BRAF, KDR, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
381 EGFR tyrosine kinase inhibitor resistance 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
382 EGFR tyrosine kinase inhibitor resistance 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
383 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
384 EGFR tyrosine kinase inhibitor resistance 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
385 EGFR tyrosine kinase inhibitor resistance 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
386 EGFR tyrosine kinase inhibitor resistance 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
387 EGFR tyrosine kinase inhibitor resistance 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
388 Endocrine and other factor-regulated calcium reabsorption 💬
 1件: ESR1 💬 D01161 💬 Fulvestrant 2件: 49, 86 💬
389 Endocrine and other factor-regulated calcium reabsorption 💬
 1件: ESR1 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
390 Endocrine and other factor-regulated calcium reabsorption 💬
 1件: ESR1 💬 D00966 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
391 Endocrine and other factor-regulated calcium reabsorption 💬
 1件: ESR1 💬 D08559 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
392 Endocrine resistance 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
393 Endocrine resistance 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
394 Endocrine resistance 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
395 Endocrine resistance 💬
 2件: ESR1, ESR2 💬 D01161 💬 Fulvestrant 2件: 49, 86 💬
396 Endocrine resistance 💬
 2件: ESR1, ESR2 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
397 Endocrine resistance 💬
 2件: ESR1, ESR2 💬 D00966 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
398 Endocrine resistance 💬
 2件: ESR1, ESR2 💬 D08559 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
399 Endocrine resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
400 Endocytosis 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
401 Endocytosis 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
402 Endocytosis 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
403 Endocytosis 💬
 1件: PDGFRA 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
404 Endometrial cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
405 Endometrial cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
406 Endometrial cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
407 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
408 ErbB signaling pathway 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
409 ErbB signaling pathway 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
410 ErbB signaling pathway 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
411 ErbB signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
412 ErbB signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
413 ErbB signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
414 ErbB signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
415 Estrogen signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
416 Estrogen signaling pathway 💬
 2件: ESR1, ESR2 💬 D01161 💬 Fulvestrant 2件: 49, 86 💬
417 Estrogen signaling pathway 💬
 2件: ESR1, ESR2 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
418 Estrogen signaling pathway 💬
 2件: ESR1, ESR2 💬 D00966 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
419 Estrogen signaling pathway 💬
 2件: ESR1, ESR2 💬 D08559 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
420 Estrogen signaling pathway 💬
 1件: OPRM1 💬 D00842 💬 Morphine 6件: 36, 46, 70, 85, 86, 298 💬
421 Estrogen signaling pathway 💬
 1件: OPRM1 💬 D02271 💬 Morphine 6件: 36, 46, 70, 85, 86, 298 💬
422 Estrogen signaling pathway 💬
 1件: OPRM1 💬 D08233 💬 Morphine 6件: 36, 46, 70, 85, 86, 298 💬
423 Estrogen signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
424 Estrogen signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
425 Fc epsilon RI signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
426 Fc epsilon RI signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
427 Fc gamma R-mediated phagocytosis 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
428 Fc gamma R-mediated phagocytosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
429 Fluid shear stress and atherosclerosis 💬
 1件: ACVR2A 💬 D09670 💬 Sotatercept 2件: 86, 284 💬
430 Fluid shear stress and atherosclerosis 💬
 2件: IL1R1, IL1R2 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
431 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
432 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
433 Fluid shear stress and atherosclerosis 💬
 1件: KEAP1 💬 D03846 💬 Dimethyl fumarate 5件: 13, 49, 51, 86, 296 💬
434 Fluid shear stress and atherosclerosis 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
435 Fluid shear stress and atherosclerosis 💬
 1件: NQO1 💬 D00564 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
436 Fluid shear stress and atherosclerosis 💬
 1件: NQO1 💬 D01280 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
437 Fluid shear stress and atherosclerosis 💬
 1件: NQO1 💬 D08682 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
438 Fluid shear stress and atherosclerosis 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
439 Fluid shear stress and atherosclerosis 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
440 Fluid shear stress and atherosclerosis 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
441 Focal adhesion 💬
 5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
442 Focal adhesion 💬
 5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
443 Focal adhesion 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
444 Focal adhesion 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
445 Focal adhesion 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
446 Focal adhesion 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
447 Focal adhesion 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
448 FoxO signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
449 FoxO signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
450 FoxO signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
451 FoxO signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
452 FoxO signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
453 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
454 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
455 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
456 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
457 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
458 Gap junction 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
459 Gap junction 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
460 Gap junction 💬
 1件: ADRB1 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
461 Gap junction 💬
 1件: ADRB1 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
462 Gap junction 💬
 1件: DRD2 💬 D01462 💬 Lisuride 2件:  6 , 86 💬
463 Gap junction 💬
 1件: DRD2 💬 D08132 💬 Lisuride 2件:  6 , 86 💬
464 Gap junction 💬
 1件: DRD2 💬 D01348 💬 Terguride 2件: 51, 86 💬
465 Gap junction 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
466 Gap junction 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
467 Gap junction 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
468 Gap junction 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
469 Gap junction 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
470 Gap junction 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
471 Gap junction 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
472 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 D01984 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
473 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 D04056 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
474 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 D07917 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
475 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 D09339 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
476 Gastric acid secretion 💬
 1件: CA2 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
477 Gastric acid secretion 💬
 1件: CA2 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
478 Gastric acid secretion 💬
 1件: CHRM3 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
479 Gastric acid secretion 💬
 1件: HRH2 💬 D00318 💬 Famotidine 7件:  6 , 46, 61, 86, 98, 107, 300 💬
480 Gastric cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
481 Gastric cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
482 Gastric cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
483 Gastric cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
484 Glioma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
485 Glioma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
486 Glioma 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
487 Glioma 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
488 Glioma 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
489 Glioma 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
490 Glioma 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
491 Glucagon signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
492 Glucagon signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
493 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
494 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
495 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
496 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
497 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
498 Glutathione metabolism 💬
 1件: ANPEP 💬 D00087 💬 Ubenimex 1件: 86 💬
499 Glutathione metabolism 💬
 1件: RRM2 💬 D00341 💬 Hydroxyurea 8件:  3 , 13, 19, 20, 65, 85, 86, 284 💬
500 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
501 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
502 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
503 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
504 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
505 GnRH secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
506 GnRH secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
507 GnRH secretion 💬
 1件: ESR2 💬 D01161 💬 Fulvestrant 2件: 49, 86 💬
508 GnRH secretion 💬
 1件: ESR2 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
509 GnRH secretion 💬
 1件: ESR2 💬 D00966 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
510 GnRH secretion 💬
 1件: ESR2 💬 D08559 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
511 GnRH secretion 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
512 GnRH secretion 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
513 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
514 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
515 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
516 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
517 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
518 GnRH signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
519 GnRH signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
520 GnRH signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
521 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
522 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
523 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
524 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
525 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
526 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
527 Growth hormone synthesis, secretion and action 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
528 Growth hormone synthesis, secretion and action 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
529 Hematopoietic cell lineage 💬
 1件: ANPEP 💬 D00087 💬 Ubenimex 1件: 86 💬
530 Hematopoietic cell lineage 💬
 2件: FLT3, KIT 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
531 Hematopoietic cell lineage 💬
 2件: FLT3, KIT 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
532 Hematopoietic cell lineage 💬
 2件: IL1R1, IL1R2 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
533 Hematopoietic cell lineage 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
534 Hematopoietic cell lineage 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
535 Hematopoietic cell lineage 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
536 Hematopoietic cell lineage 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
537 Hematopoietic cell lineage 💬
 1件: MS4A1 💬 D02994 💬 Rituximab 49件:  6 , 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
538 Hepatitis B 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
539 Hepatitis B 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
540 Hepatitis C 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
541 Hepatitis C 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
542 Hepatitis C 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
543 Hepatocellular carcinoma 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
544 Hepatocellular carcinoma 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
545 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
546 Hepatocellular carcinoma 💬
 1件: KEAP1 💬 D03846 💬 Dimethyl fumarate 5件: 13, 49, 51, 86, 296 💬
547 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
548 Hepatocellular carcinoma 💬
 1件: NQO1 💬 D00564 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
549 Hepatocellular carcinoma 💬
 1件: NQO1 💬 D01280 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
550 Hepatocellular carcinoma 💬
 1件: NQO1 💬 D08682 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
551 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
552 HIF-1 signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
553 HIF-1 signaling pathway 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
554 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
555 HIF-1 signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
556 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
557 Human cytomegalovirus infection 💬
 1件: IL1R1 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
558 Human cytomegalovirus infection 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
559 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
560 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
561 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
562 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
563 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
564 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
565 Human cytomegalovirus infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
566 Human cytomegalovirus infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
567 Human cytomegalovirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
568 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
569 Human immunodeficiency virus 1 infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
570 Human immunodeficiency virus 1 infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
571 Human papillomavirus infection 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
572 Human papillomavirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
573 Human papillomavirus infection 💬
 1件: PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
574 Human papillomavirus infection 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
575 Human papillomavirus infection 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
576 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
577 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
578 Human papillomavirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
579 Human T-cell leukemia virus 1 infection 💬
 2件: IL1R1, IL1R2 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
580 Huntington disease 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
581 Huntington disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
582 Huntington disease 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
583 Huntington disease 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
584 Hypertrophic cardiomyopathy 💬
 1件: ACE 💬 D00251 💬 Captopril 8件:  6 , 17, 46, 86, 96, 97, 107, 271 💬
585 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
586 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
587 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
588 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
589 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
590 Hypertrophic cardiomyopathy 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
591 Hypertrophic cardiomyopathy 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
592 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
593 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
594 Inflammatory mediator regulation of TRP channels 💬
 1件: HRH1 💬 D00300 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
595 Inflammatory mediator regulation of TRP channels 💬
 1件: HRH1 💬 D00669 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
596 Inflammatory mediator regulation of TRP channels 💬
 1件: HRH1 💬 D02419 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
597 Inflammatory mediator regulation of TRP channels 💬
 1件: HRH1 💬 D03285 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
598 Inflammatory mediator regulation of TRP channels 💬
 1件: HRH1 💬 D03360 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
599 Inflammatory mediator regulation of TRP channels 💬
 1件: HRH1 💬 D03854 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
600 Inflammatory mediator regulation of TRP channels 💬
 1件: IL1R1 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
601 Inflammatory mediator regulation of TRP channels 💬
 1件: TRPV1 💬 D00250 💬 Capsaicin 5件:  2 ,  6 , 19, 86, 226 💬
602 Influenza A 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
603 Influenza A 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
604 Insulin resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
605 Insulin resistance 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
606 Insulin resistance 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
607 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
608 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
609 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
610 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
611 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
612 Insulin secretion 💬
 1件: CHRM3 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
613 Insulin signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
614 Insulin signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
615 Insulin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
616 Insulin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
617 Insulin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
618 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
619 JAK-STAT signaling pathway 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
620 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
621 JAK-STAT signaling pathway 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
622 JAK-STAT signaling pathway 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
623 JAK-STAT signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
624 JAK-STAT signaling pathway 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
625 JAK-STAT signaling pathway 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
626 JAK-STAT signaling pathway 💬
 1件: PRL 💬 D01348 💬 Terguride 2件: 51, 86 💬
627 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
628 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
629 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
630 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
631 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
632 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
633 Leishmaniasis 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
634 Leishmaniasis 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
635 Lipid and atherosclerosis 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
636 Lipid and atherosclerosis 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
637 Lipid and atherosclerosis 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
638 Long-term depression 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
639 Long-term depression 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
640 Long-term depression 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
641 Long-term potentiation 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
642 Long-term potentiation 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
643 Long-term potentiation 💬
 1件: CACNA1C 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
644 Long-term potentiation 💬
 1件: CACNA1C 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
645 Long-term potentiation 💬
 1件: CACNA1C 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
646 Long-term potentiation 💬
 1件: CACNA1C 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
647 Long-term potentiation 💬
 1件: CACNA1C 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
648 Longevity regulating pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
649 Longevity regulating pathway 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
650 Longevity regulating pathway 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
651 Longevity regulating pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
652 Longevity regulating pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
653 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
654 Longevity regulating pathway - multiple species 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
655 Longevity regulating pathway - multiple species 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
656 MAPK signaling pathway 💬
 7件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
657 MAPK signaling pathway 💬
 7件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
658 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
659 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
660 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
661 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
662 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
663 MAPK signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
664 MAPK signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
665 MAPK signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
666 MAPK signaling pathway 💬
 1件: IL1R1 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
667 MAPK signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
668 MAPK signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
669 MAPK signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
670 MAPK signaling pathway 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
671 MAPK signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
672 Melanogenesis 💬
 1件: EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
673 Melanogenesis 💬
 1件: EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
674 Melanogenesis 💬
 1件: EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
675 Melanogenesis 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
676 Melanogenesis 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
677 Melanogenesis 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
678 Melanogenesis 💬
 2件: KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
679 Melanogenesis 💬
 2件: KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
680 Melanoma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
681 Melanoma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
682 Melanoma 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
683 Melanoma 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
684 Melanoma 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
685 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
686 Metabolic pathways 💬
 1件: ANPEP 💬 D00087 💬 Ubenimex 1件: 86 💬
687 Metabolic pathways 💬
 2件: ATP4A, ATP4B 💬 D01984 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
688 Metabolic pathways 💬
 2件: ATP4A, ATP4B 💬 D04056 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
689 Metabolic pathways 💬
 2件: ATP4A, ATP4B 💬 D07917 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
690 Metabolic pathways 💬
 2件: ATP4A, ATP4B 💬 D09339 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
691 Metabolic pathways 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
692 Metabolic pathways 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
693 Metabolic pathways 💬
 1件: CYP19A1 💬 D00960 💬 Anastrozole 3件: 78, 86, 193 💬
694 Metabolic pathways 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
695 Metabolic pathways 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
696 Metabolic pathways 💬
 2件: NQO1, VKORC1 💬 D00564 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
697 Metabolic pathways 💬
 2件: NQO1, VKORC1 💬 D01280 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
698 Metabolic pathways 💬
 2件: NQO1, VKORC1 💬 D08682 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
699 Metabolic pathways 💬
 1件: PDE5A 💬 D02229 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
700 Metabolic pathways 💬
 1件: PDE5A 💬 D08514 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
701 Metabolic pathways 💬
 1件: PDE5A 💬 D02008 💬 Tadalafil 7件:  6 , 51, 75, 84, 86, 113, 210 💬
702 Metabolic pathways 💬
 1件: PDE5A 💬 D10027 💬 Udenafil 2件: 86, 210 💬
703 Metabolic pathways 💬
 1件: PDE5A 💬 D02731 💬 Vardenafil 3件: 13, 86, 299 💬
704 Metabolic pathways 💬
 1件: PDE5A 💬 D03260 💬 Vardenafil 3件: 13, 86, 299 💬
705 Metabolic pathways 💬
 1件: PDE5A 💬 D08668 💬 Vardenafil 3件: 13, 86, 299 💬
706 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
707 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
708 Metabolic pathways 💬
 1件: RRM2 💬 D00341 💬 Hydroxyurea 8件:  3 , 13, 19, 20, 65, 85, 86, 284 💬
709 MicroRNAs in cancer 💬
 2件: ABL1, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
710 MicroRNAs in cancer 💬
 2件: ABL1, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
711 MicroRNAs in cancer 💬
 3件: ABL1, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
712 MicroRNAs in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
713 MicroRNAs in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
714 MicroRNAs in cancer 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
715 MicroRNAs in cancer 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
716 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
717 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
718 MicroRNAs in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
719 Morphine addiction 💬
 1件: OPRM1 💬 D00842 💬 Morphine 6件: 36, 46, 70, 85, 86, 298 💬
720 Morphine addiction 💬
 1件: OPRM1 💬 D02271 💬 Morphine 6件: 36, 46, 70, 85, 86, 298 💬
721 Morphine addiction 💬
 1件: OPRM1 💬 D08233 💬 Morphine 6件: 36, 46, 70, 85, 86, 298 💬
722 mTOR signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
723 mTOR signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
724 mTOR signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
725 mTOR signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
726 mTOR signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
727 Natural killer cell mediated cytotoxicity 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
728 Natural killer cell mediated cytotoxicity 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
729 Necroptosis 💬
 1件: PARP1 💬 D09730 💬 Olaparib 2件: 86, 285 💬
730 Neuroactive ligand-receptor interaction 💬
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
731 Neuroactive ligand-receptor interaction 💬
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
732 Neuroactive ligand-receptor interaction 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
733 Neuroactive ligand-receptor interaction 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
734 Neuroactive ligand-receptor interaction 💬
 1件: ADRB2 💬 D02147 💬 Salbutamol 14件:  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
735 Neuroactive ligand-receptor interaction 💬
 2件: AGTR1, AGTR2 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
736 Neuroactive ligand-receptor interaction 💬
 2件: AGTR1, AGTR2 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
737 Neuroactive ligand-receptor interaction 💬
 2件: AVPR1A, AVPR2 💬 D01236 💬 Conivaptan 1件: 86 💬
738 Neuroactive ligand-receptor interaction 💬
 2件: AVPR1A, AVPR2 💬 D07748 💬 Conivaptan 1件: 86 💬
739 Neuroactive ligand-receptor interaction 💬
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
740 Neuroactive ligand-receptor interaction 💬
 3件: DRD2, DRD3, DRD4 💬 D01462 💬 Lisuride 2件:  6 , 86 💬
741 Neuroactive ligand-receptor interaction 💬
 3件: DRD2, DRD3, DRD4 💬 D08132 💬 Lisuride 2件:  6 , 86 💬
742 Neuroactive ligand-receptor interaction 💬
 2件: DRD2, PRL 💬 D01348 💬 Terguride 2件: 51, 86 💬
743 Neuroactive ligand-receptor interaction 💬
 1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
744 Neuroactive ligand-receptor interaction 💬
 1件: EDNRA 💬 D07171 💬 Sitaxentan 1件: 86 💬
745 Neuroactive ligand-receptor interaction 💬
 2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
746 Neuroactive ligand-receptor interaction 💬
 2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
747 Neuroactive ligand-receptor interaction 💬
 2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
748 Neuroactive ligand-receptor interaction 💬
 1件: HRH1 💬 D00300 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
749 Neuroactive ligand-receptor interaction 💬
 1件: HRH1 💬 D00669 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
750 Neuroactive ligand-receptor interaction 💬
 1件: HRH1 💬 D02419 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
751 Neuroactive ligand-receptor interaction 💬
 1件: HRH1 💬 D03285 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
752 Neuroactive ligand-receptor interaction 💬
 1件: HRH1 💬 D03360 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
753 Neuroactive ligand-receptor interaction 💬
 1件: HRH1 💬 D03854 💬 Diphenhydramine 10件: 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 💬
754 Neuroactive ligand-receptor interaction 💬
 1件: HRH2 💬 D00318 💬 Famotidine 7件:  6 , 46, 61, 86, 98, 107, 300 💬
755 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00407 💬 Methylprednisolone 48件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
756 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00751 💬 Methylprednisolone 48件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
757 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00979 💬 Methylprednisolone 48件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
758 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D05000 💬 Methylprednisolone 48件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
759 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D05001 💬 Methylprednisolone 48件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
760 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D05002 💬 Methylprednisolone 48件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
761 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00473 💬 Prednisone 48件:  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
762 Neuroactive ligand-receptor interaction 💬
 1件: OPRM1 💬 D00842 💬 Morphine 6件: 36, 46, 70, 85, 86, 298 💬
763 Neuroactive ligand-receptor interaction 💬
 1件: OPRM1 💬 D02271 💬 Morphine 6件: 36, 46, 70, 85, 86, 298 💬
764 Neuroactive ligand-receptor interaction 💬
 1件: OPRM1 💬 D08233 💬 Morphine 6件: 36, 46, 70, 85, 86, 298 💬
765 Neuroactive ligand-receptor interaction 💬
 1件: PTGIR 💬 D02720 💬 Beraprost 1件: 86 💬
766 Neuroactive ligand-receptor interaction 💬
 1件: PTGIR 💬 D00106 💬 Epoprostenol 1件: 86 💬
767 Neuroactive ligand-receptor interaction 💬
 1件: PTGIR 💬 D01337 💬 Epoprostenol 1件: 86 💬
768 Neuroactive ligand-receptor interaction 💬
 1件: PTGIR 💬 D02721 💬 Iloprost 4件: 51, 84, 85, 86 💬
769 Neuroactive ligand-receptor interaction 💬
 1件: PTGIR 💬 D10725 💬 Ralinepag 1件: 86 💬
770 Neuroactive ligand-receptor interaction 💬
 1件: PTGIR 💬 D09994 💬 Selexipag 6件: 47, 51, 70, 84, 86, 88 💬
771 Neuroactive ligand-receptor interaction 💬
 1件: PTGIR 💬 D06213 💬 Treprostinil 6件: 51, 84, 85, 86, 88, 210 💬
772 Neuroactive ligand-receptor interaction 💬
 1件: TBXA2R 💬 D04500 💬 Ifetroban 3件: 51, 86, 113 💬
773 Neuroactive ligand-receptor interaction 💬
 1件: TRPV1 💬 D00250 💬 Capsaicin 5件:  2 ,  6 , 19, 86, 226 💬
774 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
775 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
776 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
777 Neurotrophin signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
778 Neurotrophin signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
779 Neurotrophin signaling pathway 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
780 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
781 Neutrophil extracellular trap formation 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
782 Neutrophil extracellular trap formation 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
783 NF-kappa B signaling pathway 💬
 1件: IL1R1 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
784 NF-kappa B signaling pathway 💬
 1件: PARP1 💬 D09730 💬 Olaparib 2件: 86, 285 💬
785 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
786 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
787 Nitrogen metabolism 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
788 Nitrogen metabolism 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
789 Non-alcoholic fatty liver disease 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
790 Non-alcoholic fatty liver disease 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
791 Non-alcoholic fatty liver disease 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
792 Non-alcoholic fatty liver disease 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
793 Non-alcoholic fatty liver disease 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
794 Non-alcoholic fatty liver disease 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
795 Non-small cell lung cancer 💬
 3件: BRAF, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
796 Non-small cell lung cancer 💬
 3件: BRAF, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
797 Non-small cell lung cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
798 Oocyte meiosis 💬
 1件: AR 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
799 Osteoclast differentiation 💬
 1件: IL1R1 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
800 Osteoclast differentiation 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
801 Osteoclast differentiation 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
802 Ovarian steroidogenesis 💬
 1件: CYP19A1 💬 D00960 💬 Anastrozole 3件: 78, 86, 193 💬
803 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
804 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
805 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 D01984 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
806 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 D04056 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
807 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 D07917 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
808 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 D09339 💬 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
809 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
810 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
811 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
812 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
813 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
814 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
815 Oxytocin signaling pathway 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
816 Oxytocin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
817 Oxytocin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
818 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
819 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
820 Oxytocin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
821 Oxytocin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
822 p53 signaling pathway 💬
 1件: RRM2 💬 D00341 💬 Hydroxyurea 8件:  3 , 13, 19, 20, 65, 85, 86, 284 💬
823 Pancreatic cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
824 Pancreatic cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
825 Pancreatic cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
826 Pancreatic cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
827 Pancreatic cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
828 Pancreatic secretion 💬
 1件: CA2 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
829 Pancreatic secretion 💬
 1件: CA2 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
830 Pancreatic secretion 💬
 1件: CHRM3 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
831 Parathyroid hormone synthesis, secretion and action 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
832 Parathyroid hormone synthesis, secretion and action 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
833 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
834 Parkinson disease 💬
 1件: DRD2 💬 D01462 💬 Lisuride 2件:  6 , 86 💬
835 Parkinson disease 💬
 1件: DRD2 💬 D08132 💬 Lisuride 2件:  6 , 86 💬
836 Parkinson disease 💬
 1件: DRD2 💬 D01348 💬 Terguride 2件: 51, 86 💬
837 Parkinson disease 💬
 1件: KEAP1 💬 D03846 💬 Dimethyl fumarate 5件: 13, 49, 51, 86, 296 💬
838 Parkinson disease 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
839 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
840 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
841 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
842 Pathogenic Escherichia coli infection 💬
 1件: IL1R1 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
843 Pathways in cancer 💬
 3件: ABL1, KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
844 Pathways in cancer 💬
 3件: ABL1, KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
845 Pathways in cancer 💬
 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
846 Pathways in cancer 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
847 Pathways in cancer 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
848 Pathways in cancer 💬
 3件: AR, ESR1, ESR2 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
849 Pathways in cancer 💬
 7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
850 Pathways in cancer 💬
 7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
851 Pathways in cancer 💬
 1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
852 Pathways in cancer 💬
 1件: EDNRA 💬 D07171 💬 Sitaxentan 1件: 86 💬
853 Pathways in cancer 💬
 2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
854 Pathways in cancer 💬
 2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
855 Pathways in cancer 💬
 2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
856 Pathways in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
857 Pathways in cancer 💬
 2件: ESR1, ESR2 💬 D01161 💬 Fulvestrant 2件: 49, 86 💬
858 Pathways in cancer 💬
 2件: ESR1, ESR2 💬 D00966 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
859 Pathways in cancer 💬
 2件: ESR1, ESR2 💬 D08559 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
860 Pathways in cancer 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
861 Pathways in cancer 💬
 1件: KEAP1 💬 D03846 💬 Dimethyl fumarate 5件: 13, 49, 51, 86, 296 💬
862 Pathways in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
863 Pathways in cancer 💬
 1件: NQO1 💬 D00564 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
864 Pathways in cancer 💬
 1件: NQO1 💬 D01280 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
865 Pathways in cancer 💬
 1件: NQO1 💬 D08682 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
866 Pathways in cancer 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
867 Pathways in cancer 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
868 Pathways in cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
869 Pathways in cancer 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
870 Pathways in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
871 Pathways of neurodegeneration - multiple diseases 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
872 Pathways of neurodegeneration - multiple diseases 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
873 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
874 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
875 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
876 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
877 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
878 Pathways of neurodegeneration - multiple diseases 💬
 3件: CHRM1, CHRM3, CHRM5 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
879 Pathways of neurodegeneration - multiple diseases 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
880 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
881 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
882 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
883 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
884 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
885 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
886 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
887 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
888 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
889 Phospholipase D signaling pathway 💬
 2件: AVPR1A, AVPR2 💬 D01236 💬 Conivaptan 1件: 86 💬
890 Phospholipase D signaling pathway 💬
 2件: AVPR1A, AVPR2 💬 D07748 💬 Conivaptan 1件: 86 💬
891 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
892 Phospholipase D signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
893 Phospholipase D signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
894 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
895 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
896 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
897 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
898 PI3K-Akt signaling pathway 💬
 2件: CHRM1, CHRM2 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
899 PI3K-Akt signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
900 PI3K-Akt signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
901 PI3K-Akt signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
902 PI3K-Akt signaling pathway 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
903 PI3K-Akt signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
904 PI3K-Akt signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
905 PI3K-Akt signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
906 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
907 PI3K-Akt signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
908 PI3K-Akt signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
909 PI3K-Akt signaling pathway 💬
 1件: PRL 💬 D01348 💬 Terguride 2件: 51, 86 💬
910 PI3K-Akt signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
911 Platelet activation 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
912 Platelet activation 💬
 1件: P2RY12 💬 D00769 💬 Clopidogrel 2件: 49, 86 💬
913 Platelet activation 💬
 1件: P2RY12 💬 D07729 💬 Clopidogrel 2件: 49, 86 💬
914 Platelet activation 💬
 1件: P2RY12 💬 D10823 💬 Clopidogrel 2件: 49, 86 💬
915 Platelet activation 💬
 1件: P2RY12 💬 D10824 💬 Clopidogrel 2件: 49, 86 💬
916 Platelet activation 💬
 1件: PTGIR 💬 D02720 💬 Beraprost 1件: 86 💬
917 Platelet activation 💬
 1件: PTGIR 💬 D00106 💬 Epoprostenol 1件: 86 💬
918 Platelet activation 💬
 1件: PTGIR 💬 D01337 💬 Epoprostenol 1件: 86 💬
919 Platelet activation 💬
 1件: PTGIR 💬 D02721 💬 Iloprost 4件: 51, 84, 85, 86 💬
920 Platelet activation 💬
 1件: PTGIR 💬 D10725 💬 Ralinepag 1件: 86 💬
921 Platelet activation 💬
 1件: PTGIR 💬 D09994 💬 Selexipag 6件: 47, 51, 70, 84, 86, 88 💬
922 Platelet activation 💬
 1件: PTGIR 💬 D06213 💬 Treprostinil 6件: 51, 84, 85, 86, 88, 210 💬
923 Platelet activation 💬
 1件: PTGS1 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
924 Platelet activation 💬
 1件: PTGS1 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
925 Platelet activation 💬
 1件: TBXA2R 💬 D04500 💬 Ifetroban 3件: 51, 86, 113 💬
926 Platinum drug resistance 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
927 PPAR signaling pathway 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
928 PPAR signaling pathway 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
929 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
930 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
931 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
932 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
933 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
934 Progesterone-mediated oocyte maturation 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
935 Progesterone-mediated oocyte maturation 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
936 Prolactin signaling pathway 💬
 2件: ESR1, ESR2 💬 D01161 💬 Fulvestrant 2件: 49, 86 💬
937 Prolactin signaling pathway 💬
 2件: ESR1, ESR2 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
938 Prolactin signaling pathway 💬
 2件: ESR1, ESR2 💬 D00966 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
939 Prolactin signaling pathway 💬
 2件: ESR1, ESR2 💬 D08559 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
940 Prolactin signaling pathway 💬
 1件: PRL 💬 D01348 💬 Terguride 2件: 51, 86 💬
941 Prolactin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
942 Prolactin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
943 Prostate cancer 💬
 1件: AR 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
944 Prostate cancer 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
945 Prostate cancer 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
946 Prostate cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
947 Prostate cancer 💬
 1件: IL1R2 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
948 Prostate cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
949 Prostate cancer 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
950 Prostate cancer 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
951 Prostate cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
952 Protein processing in endoplasmic reticulum 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
953 Proteoglycans in cancer 💬
 3件: BRAF, KDR, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
954 Proteoglycans in cancer 💬
 3件: BRAF, KDR, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
955 Proteoglycans in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
956 Proteoglycans in cancer 💬
 1件: ESR1 💬 D01161 💬 Fulvestrant 2件: 49, 86 💬
957 Proteoglycans in cancer 💬
 1件: ESR1 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
958 Proteoglycans in cancer 💬
 1件: ESR1 💬 D00966 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
959 Proteoglycans in cancer 💬
 1件: ESR1 💬 D08559 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
960 Proteoglycans in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
961 Proteoglycans in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
962 Proximal tubule bicarbonate reclamation 💬
 2件: CA2, CA4 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
963 Proximal tubule bicarbonate reclamation 💬
 2件: CA2, CA4 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
964 Purine metabolism 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
965 Purine metabolism 💬
 1件: PDE5A 💬 D02229 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
966 Purine metabolism 💬
 1件: PDE5A 💬 D08514 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
967 Purine metabolism 💬
 1件: PDE5A 💬 D02008 💬 Tadalafil 7件:  6 , 51, 75, 84, 86, 113, 210 💬
968 Purine metabolism 💬
 1件: PDE5A 💬 D10027 💬 Udenafil 2件: 86, 210 💬
969 Purine metabolism 💬
 1件: PDE5A 💬 D02731 💬 Vardenafil 3件: 13, 86, 299 💬
970 Purine metabolism 💬
 1件: PDE5A 💬 D03260 💬 Vardenafil 3件: 13, 86, 299 💬
971 Purine metabolism 💬
 1件: PDE5A 💬 D08668 💬 Vardenafil 3件: 13, 86, 299 💬
972 Purine metabolism 💬
 1件: RRM2 💬 D00341 💬 Hydroxyurea 8件:  3 , 13, 19, 20, 65, 85, 86, 284 💬
973 Pyrimidine metabolism 💬
 1件: RRM2 💬 D00341 💬 Hydroxyurea 8件:  3 , 13, 19, 20, 65, 85, 86, 284 💬
974 Rap1 signaling pathway 💬
 6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
975 Rap1 signaling pathway 💬
 6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
976 Rap1 signaling pathway 💬
 1件: DRD2 💬 D01462 💬 Lisuride 2件:  6 , 86 💬
977 Rap1 signaling pathway 💬
 1件: DRD2 💬 D08132 💬 Lisuride 2件:  6 , 86 💬
978 Rap1 signaling pathway 💬
 1件: DRD2 💬 D01348 💬 Terguride 2件: 51, 86 💬
979 Rap1 signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
980 Rap1 signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
981 Rap1 signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
982 Rap1 signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
983 Rap1 signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
984 Ras signaling pathway 💬
 3件: ABL1, KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
985 Ras signaling pathway 💬
 3件: ABL1, KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
986 Ras signaling pathway 💬
 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
987 Ras signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
988 Ras signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
989 Ras signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
990 Ras signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
991 Regulation of actin cytoskeleton 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
992 Regulation of actin cytoskeleton 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
993 Regulation of actin cytoskeleton 💬
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
994 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
995 Regulation of actin cytoskeleton 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
996 Regulation of actin cytoskeleton 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
997 Regulation of actin cytoskeleton 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
998 Regulation of lipolysis in adipocytes 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
999 Regulation of lipolysis in adipocytes 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
1000 Regulation of lipolysis in adipocytes 💬
 2件: ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
1001 Regulation of lipolysis in adipocytes 💬
 2件: ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
1002 Regulation of lipolysis in adipocytes 💬
 1件: ADRB2 💬 D02147 💬 Salbutamol 14件:  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
1003 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1004 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1005 Relaxin signaling pathway 💬
 1件: EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
1006 Relaxin signaling pathway 💬
 1件: EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
1007 Relaxin signaling pathway 💬
 1件: EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
1008 Relaxin signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1009 Relaxin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1010 Relaxin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1011 Relaxin signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1012 Renal cell carcinoma 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1013 Renal cell carcinoma 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1014 Renal cell carcinoma 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1015 Renin secretion 💬
 1件: ACE 💬 D00251 💬 Captopril 8件:  6 , 17, 46, 86, 96, 97, 107, 271 💬
1016 Renin secretion 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
1017 Renin secretion 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
1018 Renin secretion 💬
 2件: ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
1019 Renin secretion 💬
 2件: ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
1020 Renin secretion 💬
 1件: ADRB2 💬 D02147 💬 Salbutamol 14件:  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
1021 Renin secretion 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
1022 Renin secretion 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
1023 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
1024 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
1025 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
1026 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
1027 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
1028 Renin secretion 💬
 1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
1029 Renin secretion 💬
 1件: EDNRA 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
1030 Renin secretion 💬
 1件: EDNRA 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
1031 Renin secretion 💬
 1件: EDNRA 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
1032 Renin secretion 💬
 1件: EDNRA 💬 D07171 💬 Sitaxentan 1件: 86 💬
1033 Renin secretion 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
1034 Renin-angiotensin system 💬
 1件: ACE 💬 D00251 💬 Captopril 8件:  6 , 17, 46, 86, 96, 97, 107, 271 💬
1035 Renin-angiotensin system 💬
 2件: AGTR1, AGTR2 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
1036 Renin-angiotensin system 💬
 2件: AGTR1, AGTR2 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
1037 Renin-angiotensin system 💬
 1件: ANPEP 💬 D00087 💬 Ubenimex 1件: 86 💬
1038 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
1039 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
1040 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
1041 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
1042 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
1043 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1044 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1045 Rheumatoid arthritis 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1046 Salivary secretion 💬
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
1047 Salivary secretion 💬
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
1048 Salivary secretion 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
1049 Salivary secretion 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
1050 Salivary secretion 💬
 1件: ADRB2 💬 D02147 💬 Salbutamol 14件:  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
1051 Salivary secretion 💬
 1件: CHRM3 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
1052 Salivary secretion 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
1053 Salmonella infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1054 Salmonella infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1055 Serotonergic synapse 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1056 Serotonergic synapse 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1057 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
1058 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
1059 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
1060 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
1061 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
1062 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1063 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1064 Serotonergic synapse 💬
 1件: SLC6A4 💬 D00326 💬 Fluoxetine 6件: 13, 17, 78, 86, 179, 206 💬
1065 Serotonergic synapse 💬
 1件: SLC6A4 💬 D00823 💬 Fluoxetine 6件: 13, 17, 78, 86, 179, 206 💬
1066 Shigellosis 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1067 Shigellosis 💬
 1件: IL1R1 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
1068 Shigellosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1069 Signaling pathways regulating pluripotency of stem cells 💬
 1件: ACVR2A 💬 D09670 💬 Sotatercept 2件: 86, 284 💬
1070 Signaling pathways regulating pluripotency of stem cells 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1071 Signaling pathways regulating pluripotency of stem cells 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1072 Small cell lung cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1073 Small cell lung cancer 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1074 Sphingolipid signaling pathway 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
1075 Sphingolipid signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1076 Sphingolipid signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1077 Spinocerebellar ataxia 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
1078 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1079 Steroid hormone biosynthesis 💬
 1件: CYP19A1 💬 D00960 💬 Anastrozole 3件: 78, 86, 193 💬
1080 Synaptic vesicle cycle 💬
 1件: SLC6A4 💬 D00326 💬 Fluoxetine 6件: 13, 17, 78, 86, 179, 206 💬
1081 Synaptic vesicle cycle 💬
 1件: SLC6A4 💬 D00823 💬 Fluoxetine 6件: 13, 17, 78, 86, 179, 206 💬
1082 T cell receptor signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1083 T cell receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1084 Taste transduction 💬
 1件: CACNA1C 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
1085 Taste transduction 💬
 1件: CACNA1C 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
1086 Taste transduction 💬
 1件: CACNA1C 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
1087 Taste transduction 💬
 1件: CACNA1C 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
1088 Taste transduction 💬
 1件: CACNA1C 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
1089 Taste transduction 💬
 1件: CHRM3 💬 D02212 💬 Ipratropium 2件:  6 , 86 💬
1090 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
1091 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D02086 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
1092 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
1093 Taste transduction 💬
 2件: TAS1R2, TAS1R3 💬 D02381 💬 Aspartame 5件:  6 , 13, 67, 86, 230 💬
1094 Terpenoid backbone biosynthesis 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
1095 TGF-beta signaling pathway 💬
 1件: ACVR2A 💬 D09670 💬 Sotatercept 2件: 86, 284 💬
1096 Th17 cell differentiation 💬
 1件: IL1R1 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
1097 Th17 cell differentiation 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
1098 Th17 cell differentiation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1099 Thermogenesis 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
1100 Thermogenesis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1101 Thermogenesis 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
1102 Thermogenesis 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
1103 Thermogenesis 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
1104 Thermogenesis 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
1105 Thyroid cancer 💬
 2件: BRAF, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1106 Thyroid cancer 💬
 2件: BRAF, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1107 Thyroid cancer 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
1108 Thyroid cancer 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
1109 Thyroid hormone signaling pathway 💬
 1件: ESR1 💬 D01161 💬 Fulvestrant 2件: 49, 86 💬
1110 Thyroid hormone signaling pathway 💬
 1件: ESR1 💬 D08409 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬
1111 Thyroid hormone signaling pathway 💬
 1件: ESR1 💬 D00966 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
1112 Thyroid hormone signaling pathway 💬
 1件: ESR1 💬 D08559 💬 Tamoxifen 4件:  2 , 86, 113, 227 💬
1113 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1114 Thyroid hormone signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1115 Thyroid hormone signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1116 Tight junction 💬
 1件: CACNA1D 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
1117 Tight junction 💬
 1件: CACNA1D 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
1118 Tight junction 💬
 1件: CACNA1D 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
1119 Tight junction 💬
 1件: CACNA1D 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
1120 Tight junction 💬
 1件: CACNA1D 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
1121 Tight junction 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
1122 Tight junction 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
1123 Tight junction 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
1124 TNF signaling pathway 💬
 1件: MAP3K5 💬 D10988 💬 Selonsertib 1件: 86 💬
1125 TNF signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1126 TNF signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1127 Transcriptional misregulation in cancer 💬
 1件: FLT3 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1128 Transcriptional misregulation in cancer 💬
 1件: FLT3 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1129 Transcriptional misregulation in cancer 💬
 1件: IL1R2 💬 D02934 💬 Anakinra 19件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
1130 Transcriptional misregulation in cancer 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
1131 Transcriptional misregulation in cancer 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
1132 Tuberculosis 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1133 Tuberculosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1134 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
1135 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
1136 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
1137 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
1138 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
1139 Type II diabetes mellitus 💬
 1件: CACNA1G 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
1140 Type II diabetes mellitus 💬
 1件: CACNA1G 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
1141 Type II diabetes mellitus 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1142 Ubiquinone and other terpenoid-quinone biosynthesis 💬
 2件: NQO1, VKORC1 💬 D00564 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
1143 Ubiquinone and other terpenoid-quinone biosynthesis 💬
 2件: NQO1, VKORC1 💬 D01280 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
1144 Ubiquinone and other terpenoid-quinone biosynthesis 💬
 2件: NQO1, VKORC1 💬 D08682 💬 Warfarin 13件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬
1145 Ubiquitin mediated proteolysis 💬
 1件: KEAP1 💬 D03846 💬 Dimethyl fumarate 5件: 13, 49, 51, 86, 296 💬
1146 Vascular smooth muscle contraction 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
1147 Vascular smooth muscle contraction 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
1148 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D00150 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
1149 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D02014 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬
1150 Vascular smooth muscle contraction 💬
 1件: AVPR1A 💬 D01236 💬 Conivaptan 1件: 86 💬
1151 Vascular smooth muscle contraction 💬
 1件: AVPR1A 💬 D07748 💬 Conivaptan 1件: 86 💬
1152 Vascular smooth muscle contraction 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1153 Vascular smooth muscle contraction 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1154 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00616 💬 Diltiazem 3件: 51, 58, 86 💬
1155 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D03830 💬 Diltiazem 3件: 51, 58, 86 💬
1156 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07845 💬 Diltiazem 3件: 51, 58, 86 💬
1157 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00617 💬 Nicardipine 2件: 70, 86 💬
1158 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08270 💬 Nicardipine 2件: 70, 86 💬
1159 Vascular smooth muscle contraction 💬
 1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
1160 Vascular smooth muscle contraction 💬
 1件: EDNRA 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
1161 Vascular smooth muscle contraction 💬
 1件: EDNRA 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
1162 Vascular smooth muscle contraction 💬
 1件: EDNRA 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
1163 Vascular smooth muscle contraction 💬
 1件: EDNRA 💬 D07171 💬 Sitaxentan 1件: 86 💬
1164 Vascular smooth muscle contraction 💬
 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
1165 Vascular smooth muscle contraction 💬
 1件: PTGIR 💬 D02720 💬 Beraprost 1件: 86 💬
1166 Vascular smooth muscle contraction 💬
 1件: PTGIR 💬 D00106 💬 Epoprostenol 1件: 86 💬
1167 Vascular smooth muscle contraction 💬
 1件: PTGIR 💬 D01337 💬 Epoprostenol 1件: 86 💬
1168 Vascular smooth muscle contraction 💬
 1件: PTGIR 💬 D02721 💬 Iloprost 4件: 51, 84, 85, 86 💬
1169 Vascular smooth muscle contraction 💬
 1件: PTGIR 💬 D10725 💬 Ralinepag 1件: 86 💬
1170 Vascular smooth muscle contraction 💬
 1件: PTGIR 💬 D09994 💬 Selexipag 6件: 47, 51, 70, 84, 86, 88 💬
1171 Vascular smooth muscle contraction 💬
 1件: PTGIR 💬 D06213 💬 Treprostinil 6件: 51, 84, 85, 86, 88, 210 💬
1172 Vasopressin-regulated water reabsorption 💬
 1件: AVPR2 💬 D01236 💬 Conivaptan 1件: 86 💬
1173 Vasopressin-regulated water reabsorption 💬
 1件: AVPR2 💬 D07748 💬 Conivaptan 1件: 86 💬
1174 VEGF signaling pathway 💬
 2件: KDR, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1175 VEGF signaling pathway 💬
 2件: KDR, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1176 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1177 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1178 VEGF signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1179 Viral myocarditis 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1180 Viral myocarditis 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1181 Viral myocarditis 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1182 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: IL6R 💬 D02596 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬

先頭へ